Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$3.99M Sell
50,000
-1,100
-2% -$91.2K 0.02% 898
2018
Q1
$4.43M Buy
51,100
+47,000
+1,146% +$3.79M 0.02% 872
2017
Q4
$283K Hold
4,100
﹤0.01% 2924
2017
Q3
$373K Buy
4,100
+600
+17% +$51.4K ﹤0.01% 2783
2017
Q2
$261K Buy
+3,500
New +$280K ﹤0.01% 3119
2016
Q4
Sell
-11,900
Closed -$1.24M 5174
2016
Q3
$1.24M Buy
+11,900
New +$1.07M 0.01% 1608
2016
Q2
Sell
-3,200
Closed -$180K 4858
2016
Q1
$180K Sell
3,200
-9,300
-74% -$549K ﹤0.01% 3226
2015
Q4
$844K Sell
12,500
-14,200
-53% -$760K 0.01% 2092
2015
Q3
$1.24M Buy
+26,700
New +$1.29M 0.01% 1989

Other funds holding NVRO

PEAK6 Group's NVRO Position: Q1 2018 in Review

PEAK6 Group sold out of NEVRO CORP. (NVRO) in Q1 2018, closing a stake of 24,133 shares — an estimated $1.95M sold.

PEAK6 Group first reported a position in NVRO in Q1 2016 and held it in 3 quarters. The position peaked at $1.67M in Q4 2017. 197 funds tracked by Wall St. Rank hold NVRO as of Q1 2018.

  • PEAK6 Group reported no remaining NEVRO CORP. position as of Q1 2018 after selling out during the quarter.
  • PEAK6 Group sold 24,133 NEVRO CORP. shares in Q1 2018, an estimated $1.95M.
  • PEAK6 Group first reported a position in NEVRO CORP. in Q1 2016 and held it in 3 quarters.
  • PEAK6 Group's NEVRO CORP. position peaked at $1.67M in Q4 2017.
  • 197 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2018.

Based on PEAK6 Group's 13F filing for Q1 2018, filed 15 May 2018.